Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Leiner revising cold, menstrual pain, motion sickness claims in response to FDA concerns.

This article was originally published in The Tan Sheet

Executive Summary

LEINER REVISING COLD, MENSTRUAL PAIN, MOTION SICKNESS CLAIMS for three dietary supplement products after receiving recent notification from FDA that the statements, which already had been modified once, still constitute drug claims. Leiner plans to change the claims to more closely adhere to the Dietary Supplement Health & Education Act; the amended labeling will appear on the products Your Life Echinacea and Goldenseal, Your Life Dong Quai and Your Life Ginger in 1997.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086836

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel